The medication for the treatment of liver diseases and biliary tract :: Consumers survey results of for 2 quarter of 2012

Consumers survey results of for 2 quarter of 2012 in category

Digestive system and hepatology / The medication for the treatment of liver diseases and biliary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Essentiale Forte N (Sanofi)	33.33%	5

2.	1	Hepabene (ratiopharm)	20.00%	3

3.	5	Алохол (Борщагівський ХФЗ)	13.33%	2

3.		Галстена (Perrigo)	13.33%	2

3.		Карсил (Sopharma)	13.33%	2

3.	~	Легалон (Madaus)	13.33%	2

–.	~	~~Ессел Форте (Nabros Pharma)~~	~~13.33%~~	2

7.	8	Chophytol (Lab. Rosa-Phytopharma)	6.67%	1

7.		Antralum (Farmak)	6.67%	1

7.	8	Артишока екстракт Гексал (Sandoz)	6.67%	1

7.	8	Гепалекс (Sandoz)	6.67%	1

7.	9	Гепатофіт (Aim)	6.67%	1

7.	8	Енерлів (Berlin-Chemie Menarini)	6.67%	1

7.	8	Лів.52 (Фірма ТК Комфорт)	6.67%	1

7.	~	Силімарин Гексал (Sandoz)	6.67%	1

7.	~	Холензим (Belmedpreparaty)	6.67%	1

7.	9	Холензим (Біосинтез)	6.67%	1

7.		Цитраргінін (Zambon France)	6.67%	1

–.	6	~~Enterosgelum (Kreoma-Pharm)~~	~~6.67%~~	1

–.	8	~~Беластезин (Борщагівський ХФЗ)~~	~~6.67%~~	1

–.	7	~~Гербіон (KRKA)~~	~~6.67%~~	1

–.	7	~~Дуфалак (Abbott Laboratories)~~	~~6.67%~~	1

–.		Febichol (Noventis)	0.00%	0

–.		Raphacholin C (Herbapol)	0.00%	0

–.		Артіхол (Київський вітамінний завод)	0.00%	0

–.		Берези бруньки (Ternopharm)	0.00%	0

–.	9	Биликур (Sandoz)	0.00%	0

–.		Бонджигар (Herbion)	0.00%	0

–.		Бренціале Форте (Бринцалов-А)	0.00%	0

–.	8	Гепа-Мерц (Merz Pharmaceuticals)	0.00%	0

–.		Гепарсил (Стиролбіофарм)	0.00%	0

–.		Гепато-флора (Медіфлора)	0.00%	0

–.		Гепафорте (Bosnalijek)	0.00%	0

–.		Глутаргін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.	7	Дарсіл (Darnitsa)	0.00%	0

–.		Есслівер Форте (Stada)	0.00%	0

–.	9	Ліволін Форте (Mega Lifesciences)	0.00%	0

–.		Левасіл (Micro Labs)	0.00%	0

–.	9	Нукс Воміка (Heel)	0.00%	0

–.		ПМ Сірін (N. Kapharma Pharmaceuticals)	0.00%	0

–.		Силібор (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Силімарол (Євролек)	0.00%	0

–.		Симепар (Teva)	0.00%	0

–.		Фламін (Arterium Corporation)	0.00%	0

–.	9	Фосфоліп (Universal Medicare)	0.00%	0

–.	9	Холівер (Hau Giang Ph. JSK-HG Pharm)	0.00%	0

–.	9	Холагол (Teva)	0.00%	0

–.		Холе-гран (Національна гомеопатична спілка)	0.00%	0

–.	9	Цінарікс (Montavit)	0.00%	0

–.	4	~~Уролесан (Arterium Corporation)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2012, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.